SEC
SlamSEC
SearchBrowseEarnings

MoonLake Immunotherapeutics

Nasdaq:MLTX
Pharmaceutical Preparations·ZUG, V8
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Moonlake is the thirty-fifth album by Klaus Schulze. It was originally released in 2005, and, taking in consideration the previously released multi-disc box sets, it could be viewed as Schulze's ninety-sixth album.

CEO
Santos Da Silva Jorge
CFO
Bodenstedt Matthias
Revenue
—
Adj. EBITDA
-$53.8M
FY 2025
Net Income
-$36.0M
FY 2025
EPS (Diluted)
-$0.73
FY 2025
Stock Price
$17.13
+0.6%
2026-03-13
52W Range
$5.95 – $62.75
P/E Ratio
-23.5x
Market Cap
—
Cash
$180.4M
FY 2025
Total Debt
$15.0M
FY 2025
Net Cash
$165.4M
FY 2025
Enterprise Value
—
Debt / EBITDA
3.1x
FY 2025
EV / EBITDA
—
Employees
—